contract development and manufacturing organization (CDMO)
contract development and manufacturing organization (CDMO)
Regulatory Spotlight on Cleaning Validation in Biotech
📢 Cleaning validation is receiving increased attention from regulatory agencies in the biotechnology industry. 🧪🔬🏭🔍💼🔒
Novo Holdings Invests $165bn in CDMO Catalent Fueling Biotech Growth
🔍 Novo Holdings buys CDMO Catalent for $16.5bn, aiming to support its expansion in the CDMO market. 🏢💼📈
Powerhouse Partnership Forms Europe’s Top Biologics CDMO
🔬💪 Biovian and 3P Biopharmaceuticals team up to form 3PBIOVIAN, a pan-European biologics CDMO with full development and manufacturing capabilities.
Game-Changing Merger Creates European CDMO Powerhouse
🔍 Biovian and 3P Biopharmaceuticals merge to create 3PBIOVIAN, a European CDMO offering end-to-end services. 🌍👥🔬🧫🧬💪
Revolutionary Kyverna Cuts CAR-T Production to 3 Days
📰 CAR-T, a gamechanger in cancer treatment, could revolutionize patient access and save lives with Kyverna's 3-day process. 💉🔬
Revolutionary Startup Aims to Transform Cell and Gene Therapies
📰 Frustration with CDMOs fuels ambition for advanced therapy startup GDMC, offering end-to-end solutions for cell and gene therapies. 💡💪🌱🧬
Boosting Manufacturing Efficiency: AI’s Role in Cutting Costs and Enhancing Therapies
🧪 AI accelerates commercialization strategies by cutting costs and improving processes in advanced therapy manufacturing. 🔬 5 of batches fail, impacting health and revenues. 🧠 AI is crucial for complex therapies. 💰 Manufacturers need to optimize processes and reduce costs. 🌐 AI enables learning transfer and supports decision-making. 📈 Industry 4.0 will use machine learning for real-time predictions and support.
Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech
📢 Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. 💼🌐💪📈
Pluri Revolutionizes Cell Therapy with Expanded CDMO Services
🌟 Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. 🚀
Sleep Tech Startup Onera Health Raises $32M in Funding
📢 Sleep diagnostics specialist Onera Health raises €30m ($32m) in Series C round, accelerating manufacturing and expanding devices. 💤💰
